<div class="article">
	<h3>Financing Business:
   Mycogen Corp.</h3>
	<div class="article-info">
		<ul>
			<li>Author: null</li>
			<li>Date: 06/06/90</li>
		</ul>
	</div>
	<p class="article-leader">MYCOGEN Corp., San Diego, announced a public offering of
2.5 million common shares at $17.75 each, boosting its common
shares outstanding to 11,228,655. Mycogen said Morgan Stanley
& Co. will lead the underwriters. The maker of biological
pesticides said proceeds will be used for general corporate
purposes and to support research, development, manufacturing
and marketing of its biopesticide products.</p>
	<div class="article-body"><p></p></div>
</div>
